Alzheimer disease
A mind map of Alzheimer disease
Diagnosis
The physician will then run tests:
Brain imaging
MRI,
CT scan
PET
Laboratory tests
Memory tests
Neuropsychological tests
Mental status testing
Alzheimer’s disease
Epidemiology
Globally, about 29.8 million people have AD as of 2015
In a study conducted in the US people aged >70 years yielded a prevalence for AD of 9.7 %.
Pathophysiology alterations
Plaque tangles and tau proteins leads to death of neuronal cell
Risk Factors
Hereditary
Abnormal amyloid precursor protein 14 [APP14]
Abnormal presenilin 1 [PSEN1] and
Abnormal presenilin 2 [PSEN2])
Cardiovascular disease
Clinical Manifestation
Behavior changes
Memory loss
Support groups
Treatment
Are three drugs commonly used, these are;
Razadyne (galantamine)
Aricept (donepezil)
Exelon (rivastigmine)
